Virax Biolabs Group Ltd (VRAX) Revenue 2021–2025
Virax Biolabs Group Ltd (VRAX) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$6,331FY2025 · since FY2021: $123,820 → $6,331
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $6,331 | -96.0% |
| FY2024 | $156,419 | +1727.1% |
| FY2023 | $8,561 | — |
| FY2022 | $0 | -100.0% |
| FY2021 | $123,820 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VRAX financial trends
VRAX Net incomeVRAX Net marginVRAX Gross profitVRAX Gross marginVRAX Operating incomeVRAX Operating marginVRAX Operating cash flowVRAX Free cash flowVRAX Capital expendituresVRAX Return on equityVRAX Stock buybacksVRAX Dividends paidVRAX Total assetsVRAX Total liabilitiesVRAX Shareholders’ equityVRAX overview →